Business Context and Reporting Period
Company: Apollo Investment Corporation (Note: The input metadata listed "Midcap Financial Investment Corp," but the filing text identifies the registrant as Apollo Investment Corporation, a Maryland corporation).
Reporting Period: Fiscal year ended March 31, 2014.
Business Overview: Apollo Investment Corporation is a closed-end, externally managed, non-diversified business development company (BDC) and regulated investment company (RIC). Its objective is to generate current income and capital appreciation primarily through debt investments (secured, unsecured, mezzanine) and equity in private U.S. middle-market companies. The company is managed by Apollo Investment Management, L.P. (AIM), an affiliate of Apollo Global Management, LLC.
Key Financial Metrics
| Metric | 2014 | 2013 |
|---|---|---|
| Total Investment Income | $381.3 million | $332.0 million |
| Net Investment Income | $201.2 million | $167.4 million |
| Net Realized and Unrealized Gains (Losses) | $69.6 million | ($62.9 million) |
| Net Increase in Net Assets from Operations | $270.9 million | $104.5 million |
| Net Asset Value (NAV) per Share | $8.67 | $8.27 |
| Net Investment Income per Share | $0.91 | $0.83 |
| Earnings per Share (Basic) | $1.21 | $0.51 |
| Total Debt Outstanding | $1.37 billion | $1.16 billion |
| Total Net Assets | $2.05 billion | $1.68 billion |
| Weighted Average Yield on Debt Portfolio | 11.1% | 11.9% |
| Dividends Declared per Share | $0.80 | $0.80 |
Material Changes vs. Prior Period
- Portfolio Growth: The portfolio expanded significantly, growing from 81 to 111 portfolio companies. Investments made totaled $2.8 billion in 2014 compared to $1.5 billion in 2013.
- Income Growth: Total investment income increased by approximately 15% to $381.3 million, driven by a larger portfolio and higher income from prepayment fees ($24.8 million vs. $7.3 million in 2013), partially offset by a decline in portfolio yield.
- Expense Increase: Net expenses rose to $180.1 million from $164.6 million, primarily due to increased interest and debt expenses ($10.4 million increase) and higher management/incentive fees.
- Realized Gains/Losses: The company reported a net realized loss of $106.5 million in 2014, compared to $74.7 million in 2013. However, this was offset by a significant net change in unrealized gains of $176.1 million, reversing previous losses on exited positions.
- Portfolio Composition: The mix shifted toward secured debt, which comprised 56% of the portfolio at fair value in 2014, up from 44% in 2013. Unsecured debt decreased from 43% to 27%.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary & Outlook: Management attributes the improvement in results to a larger investment portfolio and stronger capital market conditions. The company continues to focus on generating current income through debt investments in middle-market companies. No specific forward-looking financial guidance was provided in the text.
Risks and Contingencies:
- Legal Proceedings: The company is a defendant in a lawsuit filed by the bankruptcy trustee of DSI Renal Holdings, alleging fraudulent conveyance. The complaint seeks approximately $41 million in damages from the company. The company intends to vigorously defend itself.
- Liquidity and Debt Maturities: The company has significant debt maturities, including $225 million in Senior Secured Notes due in 2015 and $200 million in Convertible Notes due in 2016. The Senior Secured Facility begins amortizing in September 2017.
- Valuation Risk: A significant portion of the portfolio (56% or $1.9 billion) is classified as Level 3 assets, valued using unobservable inputs, creating uncertainty regarding fair value.
- Regulatory Risks: As a BDC and RIC, the company faces strict asset coverage requirements and distribution obligations to maintain tax status. Failure to distribute 90% of taxable income could result in corporate-level taxation.
Key Facts for Investor Verification
- Debt Covenants: Verify continued compliance with the 2.0:1.0 asset coverage ratio and minimum stockholders' equity requirements under the Senior Secured Facility, especially given the increase in debt to $1.37 billion.
- DSI Renal Litigation: Monitor the status of the $41 million fraudulent conveyance claim and any potential impact on financial results.
- Level 3 Valuations: Review the independent valuation firm reports for the $1.9 billion in Level 3 assets to assess the stability of the reported NAV.
- Debt Refinancing: Assess the company's ability to refinance or repay the $225 million Senior Secured Notes maturing in October 2015 and the $200 million Convertible Notes maturing in January 2016.
- Dividend Sustainability: Confirm that cash flow from operations and investment sales remains sufficient to cover the $0.80 per share annual dividend requirement to maintain RIC status, particularly given the portion of income derived from Payment-in-Kind (PIK) interest.